For those reading the study protocols, what escalation steps are the arms using and how is tolerability being reported — for me at least. Been following the retatrutide trials closely. The Phase 2 data showed 24% weight loss at 48 weeks which is insane. Phase 3 is ongoing. I've been comparing the published endpoints against what people report and trying to see where they diverge.
Retatrutide Phase 3 data — what to expect and what the arms look like
Login to reply to this thread.
Login / Sign up